Roche Finance Ltd 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:49 pm Unchanged | 2022-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | Roche Finance Ltd | 462,461 4.200% | 0 (Unchanged) | Filing |
| 2021-10-04 08:54 am Purchase | 2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR | Roche Finance Ltd | 462,461 12.700% | 462,461 (New Position) | Filing |